These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7017677)

  • 1. Use of prostacyclin in regular dialysis therapy.
    Turney JH; Williams LC; Fewell MR; Parsons V; Weston MJ
    Proc Eur Dial Transplant Assoc; 1980; 17():318-22. PubMed ID: 7017677
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
    Hory B; Saunier F; Roy C; Renevier A; Kieffer Y; Saint-Hillier Y; Perol C
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2393-7. PubMed ID: 7050907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin].
    Kuźniewski M; Sułowicz W
    Przegl Lek; 1990; 47(3):328-31. PubMed ID: 2236625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of platelet aggregation inhibitor in nephrodialysis].
    Armani U; Piana A; Griffanti-Bartoli F; Altomonte F
    Arch Maragliano Patol Clin; 1979; 35(2):63-5. PubMed ID: 400622
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy.
    Turney JH; Williams LC; Fewell MR; Parsons V; Weston MJ
    Lancet; 1980 Aug; 2(8188):219-22. PubMed ID: 6105392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin prevents endothelial and platelet damage during dialysis.
    Turney JH; Dodd NJ; Williams LC; Weston MJ
    Proc Eur Dial Transplant Assoc; 1981; 18():111-6. PubMed ID: 6460240
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antirenin activity of practolol in uremic subjects under hemodialysis treatment].
    Splendiani G; Giammaria U; D'Alessandro V; Marinangeli G; De Meo F
    Minerva Nefrol; 1975; 22(2-3):93-8. PubMed ID: 1226256
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemodialysis without heparin.
    Woods HF; Weston MJ; Bunting S
    Proc Eur Dial Transplant Assoc; 1978; 15():122-9. PubMed ID: 368769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin safer than heparin in haemodialysis.
    Arze RS; Ward MK
    Lancet; 1981 Jul; 2(8236):50. PubMed ID: 6113427
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular effects of prostacyclin in man.
    Warrington SJ; O'Grady J
    Adv Prostaglandin Thromboxane Res; 1980; 7():619-24. PubMed ID: 6989189
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostacyclin in extracorporeal circulations.
    Turney JH; Dodd NJ; Weston MJ
    Lancet; 1981 May; 1(8229):1101. PubMed ID: 6112465
    [No Abstract]   [Full Text] [Related]  

  • 12. [1st intravenous administration of prostacyclin to man].
    Szczeklik A; Gryglewski R; Nizankowski R; Musiał J; Serwońska M; Pietoń R; Mruk J
    Pol Tyg Lek; 1978 Sep; 33(36):1405-8. PubMed ID: 360190
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of prostacyclin (epoprostenol) as anticoagulant in continuous renal replacement therapies: efficacy, security and cost analysis.
    Gainza FJ; Quintanilla N; Pijoan JI; Delgado S; Urbizu JM; Lampreabe I
    J Nephrol; 2006; 19(5):648-55. PubMed ID: 17136695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostacyclin in ischemic stroke].
    Nowak S; Gryglewski R; Kostka-Trabkowa E; Bieroń K; Dembińska-Kieć A; Kuśmiderski J; Błaszczyk B; Olczyk E; Markowska E; Basista M
    Przegl Lek; 1983; 40(3):315-22. PubMed ID: 6191364
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostacyclin (PGI2).
    Davies SC; Machin SJ
    Intensive Care Med; 1983; 9(2):49-52. PubMed ID: 6343445
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodialysis without heparin].
    Romão Júnior JE; Fadil MA; Zeratti AD; Sabbaga E
    Rev Hosp Clin Fac Med Sao Paulo; 1983; 38(2):70-2. PubMed ID: 6648231
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy anticoagulation in extracorporeal hemodialysis by simultaneous administration of low-dose prostacyclin and low molecular weight heparin.
    Camici M; Giordani R; Morelli E; Meriggioli M; Balestri PL; Barsotti G; Sagripanti A
    Minerva Med; 1998; 89(11-12):405-9. PubMed ID: 10212664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the behavioral and hypotensive effects of intraventricular prostacyclin (PGI2) in rats.
    Brus K; Szkilnik R; Słomińska-Zurek J; Krzemiński T; Herman ZS
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):467-74. PubMed ID: 7036117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of regular dialysis treatment in Japan as of 31 December 2003.
    Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial; 2005 Dec; 9(6):431-58. PubMed ID: 16354276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimizing hemorrhagic complications in dialysis patients.
    Lohr JW; Schwab SJ
    J Am Soc Nephrol; 1991 Nov; 2(5):961-75. PubMed ID: 1760540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.